This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332.
Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564–569.
Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102: 3759–3764.
Waldenstrom J . Incipient myelomatosis or ‘‘essential’’ hyperglobulinemia with fibrinogenopenia—a new syndrome? Acta Med Scand 1944; 117: 216–247.
Kristinsson SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O . Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population based study in Sweden. Blood 2008; 112: 3052–3056.
Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al. MYD88 L265P somatic mutation in Waldenstrom’s macroglobulinemia. N Engl J Med 2012; 367: 826–833.
Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X et al. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013; 121: 2051–2058.
Landgren O, Staudt L . MYD88 L265P somatic mutation in IgM MGUS [letter]. N Engl J Med 2012; 367: 23.
Jiménez C, Sebastián E, Del Carmen Chillón M, Giraldo P, Mariano Hernández J, Escalante F et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia. Leukemia 2013; 27: 1722–1728.
Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom’s macroglobulinemia and related lymphoid neoplasms. Blood 2013; 121: 2522–2528.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues 4th edn. IARC Press: Lyon, France, 2008; pp 194–195.
Leren TP, Rodningen OK, Rosby O, Solberg K, Berg K . Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads. Biotechniques 1993; 14: 618–623.
Zakeri H, Ampaaro G, Chen SM, Spurgeon S, Kwok PY . Peak height patterns in dichloro-rhodamine and energy transfer dye terminator sequencing. Biotechniques 1998; 25: 406–413.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Argentou, N., Vassilopoulos, G., Ioannou, M. et al. Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders. Leukemia 28, 447–449 (2014). https://doi.org/10.1038/leu.2013.294
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.294